Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
This study is ongoing, but not recruiting participants.
Study NCT00003405 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia
Additional conditions recognized in this trial
Leukemia, Myeloid
Leukemia, Myeloid, Acute
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
recombinant interferon alfa
amifostine trihydrate
bromodeoxyuridine
cytarabine
idarubicin
idoxuridine
isotretinoin
mitoxantrone hydrochloride
Additional drug interventions recognized in this trial
Amifostine
Interferon Alfa-2a
Interferon Type I, Recombinant
Interferon-alpha
Interferons
Mitoxantrone
More general drug interventions related to this trial
Analgesics
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antiviral Agents
Central Nervous System Agents
Dermatologic Agents
Enzyme Inhibitors
Growth Inhibitors
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Radiation-Sensitizing Agents
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Rush University Medical Center
National Cancer Institute (NCI)
Back to top of Main Content
